Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elisabeth George

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
The Lancet. Oncology|March 31, 2015
NICE guidance on pomalidomide for relapsed and refractory multiple myeloma previously treated with lenalidomide and bortezomibMartyn J Burke, Elisabeth George, Amanda I Adler
The Lancet. Oncology|October 2, 2012
NICE guidance on abiraterone for castration-resistant metastatic prostate cancer previously treated with a docetaxel-containing regimenMatthew Dyer, Fiona Rinaldi, Elisabeth George, et al.
The Lancet. Oncology|April 3, 2018
NICE guidance on everolimus in combination with exemestane for treatment of advanced HER2-negative, hormone-receptor-positive breast cancer after endocrine therapyMartyn J Burke, Zoe Garrett, Elisabeth George, et al.
The Lancet. Oncology|July 26, 2015
NICE guidance on nintedanib for previously treated locally advanced, metastatic, or locally recurrent non-small-cell lung cancerCaroline J Hall, Nicola Hay, Elisabeth George, et al.
The Lancet. Respiratory Medicine|December 11, 2013
NICE guidance on inhaled mannitol for treatment of cystic fibrosisGrace Jennings, Pall F Jonsson, Elisabeth George, et al.
The Lancet. Respiratory Medicine|January 17, 2014
NICE guidance on omalizumab for severe asthmaRichard A Diaz, Zoe Charles, Elisabeth George, et al.
The Journal of Nursing Administration|December 21, 2022
Coaching to Bedside Shift Report and Its Correlation to Hospital Consumer Assessment of Healthcare Providers and Systems and Value-Based Purchasing Dimension Scores: A Multihospital Implementation StudyLauren O'Donnell, Elisabeth George, James Donnelly, et al.
The Lancet. Neurology|August 29, 2017
Dimethyl fumarate for relapsing-remitting multiple sclerosisMartyn J Burke, Joanna Richardson, Elisabeth George, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 18, 2014
The Health Technology Assessment of companion diagnostics: experience of NICESarah K Byron, Nick Crabb, Elisabeth George, et al.
Journal of Nursing Care Quality|October 14, 2022
Ensuring Rapid Response Team Care Aligns With Patients' Limitations of Medical Therapy: A Quality Improvement ProjectNicolette C Mininni, Kimberly Whiteman, Kimberly Stephens, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
The Lancet. Oncology|March 31, 2015
NICE guidance on pomalidomide for relapsed and refractory multiple myeloma previously treated with lenalidomide and bortezomibMartyn J Burke, Elisabeth George, Amanda I Adler
The Lancet. Oncology|October 2, 2012
NICE guidance on abiraterone for castration-resistant metastatic prostate cancer previously treated with a docetaxel-containing regimenMatthew Dyer, Fiona Rinaldi, Elisabeth George, et al.
The Lancet. Oncology|April 3, 2018
NICE guidance on everolimus in combination with exemestane for treatment of advanced HER2-negative, hormone-receptor-positive breast cancer after endocrine therapyMartyn J Burke, Zoe Garrett, Elisabeth George, et al.
The Lancet. Oncology|July 26, 2015
NICE guidance on nintedanib for previously treated locally advanced, metastatic, or locally recurrent non-small-cell lung cancerCaroline J Hall, Nicola Hay, Elisabeth George, et al.
The Lancet. Respiratory Medicine|December 11, 2013
NICE guidance on inhaled mannitol for treatment of cystic fibrosisGrace Jennings, Pall F Jonsson, Elisabeth George, et al.
The Lancet. Respiratory Medicine|January 17, 2014
NICE guidance on omalizumab for severe asthmaRichard A Diaz, Zoe Charles, Elisabeth George, et al.
The Journal of Nursing Administration|December 21, 2022
Coaching to Bedside Shift Report and Its Correlation to Hospital Consumer Assessment of Healthcare Providers and Systems and Value-Based Purchasing Dimension Scores: A Multihospital Implementation StudyLauren O'Donnell, Elisabeth George, James Donnelly, et al.
The Lancet. Neurology|August 29, 2017
Dimethyl fumarate for relapsing-remitting multiple sclerosisMartyn J Burke, Joanna Richardson, Elisabeth George, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 18, 2014
The Health Technology Assessment of companion diagnostics: experience of NICESarah K Byron, Nick Crabb, Elisabeth George, et al.
Journal of Nursing Care Quality|October 14, 2022
Ensuring Rapid Response Team Care Aligns With Patients' Limitations of Medical Therapy: A Quality Improvement ProjectNicolette C Mininni, Kimberly Whiteman, Kimberly Stephens, et al.
Pageof 4